CRISPR技術の世界市場予測(~2023年)

◆英語タイトル:CRISPR Technology Market by Product (Enzymes, Kits, gRNA, Libraries, Design Tools), Service (gRNA Design, Cell Line Engineering), Application (Biomedical, Agricultural), End User (Pharma & Biopharma Companies, Academics, CROs) - Global Forecast to 2023
◆商品コード:BT-6746
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2018年11月16日
◆ページ数:164
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

CRISPR技術の世界市場は、2018年の5億6200万米ドルから2023年には17億1500万米ドルに達し、この期間中25%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、資金調達および個人投資の増加、CRISPR術の採用の拡大などが考えれられます。一方で、代替技術も存在することから、市場の成長は抑制される可能性があります。当調査レポートでは、CRISPR技術の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品(酵素、キット、gRNA、ライブラリ、デザインツール)分析、サービス(gRNAデザイン、細胞株エンジニアリング)分析、用途(バイオメディカル、農業)分析、エンドユーザー(製薬・バイオ医薬品企業、学術機関、CRO)分析、CRISPR技術の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

“The rise in government and private funding is expected to drive the overall growth of the CRISPR technology market.”The CRISPR technology market is expected to grow from USD 562 million in 2018 to USD 1,715 million by 2023, at a CAGR of 25% during the forecast period. The CRISPR technology market is driven by various factors such as increasing funding and private investments and the growing adoption of CRISPR technology. However, the presence of alternate technologies can hinder the growth of the market.
“The CRISPR services segment is expected to grow at the highest CAGR during the forecast period.”

The CRISPR services segment is the faster-growing segment in the CRISPR technology market, by product and service. Based on services, the CRISPR services market is segmented into gRNA design and vector construction, cell line engineering, screening services, and other CRISPR services (mediated transcriptome editing and epigenome editing services). The cell line engineering services segment is expected to grow at the highest rate.
“The biomedical applications segment, by application, is projected to hold the largest market share during the forecast period.”
The major biomedical applications of CRISPR include gene therapy, drug discovery, and diagnostics. Across the globe, various gene therapy clinical trials are currently underway. These factors are expected to drive the adoption of CRISPR technology in this segment. In drug discovery applications, CRISPR is used to develop more physiologically relevant models (cell lines and animal models) that correlate better to the clinical setting and thereby reduce drug candidate failure in the initial steps. The ability of CRISPR to modify endogenous genes can help study the effect of drugs on targets along with endogenous proteins, rather than having to rely on overexpression.
“Asia Pacific is expected to record the highest growth rate during the forecast period.”
Currently, 144 gene and cell therapy companies are based in the APAC that can potentially use CRISPR technology in the coming future. In China, gene editing using CRISPR has attracted strong government funding. China was among the first to allow the editing of human embryos using CRISPR-Cas9, while the US and European countries banned it. As reported by Goldman Sachs, by the end of February 2018, China had registered nine clinical trials based on CRISPR-edited cells on various diseases such as cancers and HIV infection, whereas the US had registered only one trial since the beginning of 2018.
In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the CRISPR technology market.

By Company Type: Tier 1: 28%, Tier 2: 42%, and Tier 3: 30%
By Designation: C-level Executives: 25%, Directors: 32%, and Others: 43%
By Region: North America: 38%, Europe: 24%, APAC: 28%, and RoW: 10%

The CRISPR technology market comprises major providers such as Thermo Fisher Scientific (US), Merck KGaA (Germany), GenScript Biotech Corporation (US), Horizon Discovery (UK), Agilent (US), Cellecta (US), GeneCopoeia, Inc. (US), New England Biolabs (US), Integrated DNA Technologies (US), OriGene (US), Synthego (US) and Toolgen (S. Korea). The study includes an in-depth competitive analysis of these key players in the CRISPR technology market, along with their company profiles, recent developments, and key market strategies.
Research Coverage:
This market study covers the CRISPR technology market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, on the basis of product, service, application, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will provide market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall CRISPR technology market and its subsegments. This report will help stakeholders to understand the competitive landscape, gain insights to better position their businesses, and plan suitable go-to-market strategies. The report will also help stakeholders to understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 19
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 20
1.5 LIMITATIONS 20
2 RESEARCH METHODOLOGY 21
2.1 RESEARCH DATA 21
2.1.1 SECONDARY DATA 22
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY DATA 23
2.1.2.1 Key data from primary sources 23
2.1.2.2 Key industry insights 24
2.2 MARKET SIZE ESTIMATION 25
2.2.1 BOTTOM-UP APPROACH 25
2.2.2 TOP-DOWN APPROACH 26
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.4 ASSUMPTIONS FOR THE STUDY 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 32
4.1 CRISPR TECHNOLOGY: MARKET OVERVIEW 32
4.2 EUROPE: CRISPR TECHNOLOGY MARKET, BY END USER AND COUNTRY (2018) 33
4.3 CRISPR TECHNOLOGY MARKET, BY APPLICATIONS, 2018 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 DRIVERS 36
5.2.1.1 Rising availability of government and private funding 36
5.2.1.2 Growing adoption of CRISPR 37
5.2.2 RESTRAINTS 37
5.2.2.1 Off-target activity and the presence of alternative technologies 37
5.2.3 OPPORTUNITIES 38
5.2.3.1 Emerging markets 38
5.2.4 CHALLENGES 39
5.2.4.1 Ethical issues 39
5.2.4.2 Lack of standardized regulations 39
5.2.4.3 Pending patent issues & results of clinical trials 40
5.2.4.4 High costs of using CRISPR 41
5.2.4.5 Dearth of trained professionals 41
6 CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE 42
6.1 INTRODUCTION 43
6.2 CRISPR PRODUCTS 44
6.2.1 GROWING R&D ACTIVITIES TO DRIVE MARKET GROWTH 44
6.2.2 CRISPR ENZYMES 45
6.2.2.1 Enzymes to account for the largest share of the CRISPR products market 45
6.2.3 CRISPR LIBRARIES 46
6.2.3.1 Growing interest of researchers in the development of novel therapies is driving the adoption of CRISPR libraries 46
6.2.4 CRISPR KITS 47
6.2.4.1 Growth in awareness and increase in research activities are key factors driving market growth 47
6.2.5 OTHER CRISPR PRODUCTS 47
6.3 CRISPR SERVICES 49
6.3.1 CRISPR SERVICES TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 49
6.3.2 GRNA DESIGN & VECTOR CONSTRUCTION 50
6.3.2.1 gRNA design and vector construction segment to dominate the CRISPR services market during the forecast period 50
6.3.3 CELL LINE ENGINEERING 50
6.3.3.1 Cell line engineering to register the highest growth in the CRISPR services market during the forecast period 50
6.3.4 SCREENING SERVICES 51
6.3.4.1 CRISPR screening services are required for the genome-wide interrogation of gene function 51
6.3.5 OTHER CRISPR SERVICES 52
7 CRISPR TECHNOLOGY MARKET, BY APPLICATION 53
7.1 INTRODUCTION 54
7.2 BIOMEDICAL APPLICATIONS 54
7.2.1 ACCELERATED PROGRESS IN GENE THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS WILL DRIVE THE CRISPR TECHNOLOGY MARKET 54
7.3 AGRICULTURAL APPLICATIONS 57
7.3.1 AGRICULTURAL ACCELERATORS SET UP IN THE US, EUROPE, AND APAC ARE HELPING WITH THE COMMERCIALIZATION OF NEW CROPS 57

7.4 INDUSTRIAL APPLICATIONS 59
7.4.1 START-UPS IN THE US HAVE BEEN TAKING ADVANTAGE OF THE CRISPR TECHNOLOGY FOR INDUSTRIAL APPLICATIONS 59
7.5 BIOLOGICAL RESEARCH 61
7.5.1 PROOF-OF-CONCEPT STUDIES HELP IN DEVELOPING NEW APPLICATIONS OF CRISPR THAT CAN BE COMMERCIALIZED 61
8 CRISPR TECHNOLOGY MARKET, BY END USER 64
8.1 INTRODUCTION 65
8.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 65
8.2.1 SUCCESS OF CLINICAL TRIALS WILL PLAY A KEY ROLE IN THE CRISPR TECHNOLOGY MARKET FOR PHARMA AND BIOPHARMA COMPANIES 65
8.3 BIOTECHNOLOGY COMPANIES 68
8.3.1 RISING INTEREST OF BIOAGRICULTURAL AND BIOINDUSTRIAL COMPANIES IN CRISPR TO SPUR MARKET GROWTH 68
8.4 ACADEMIC & RESEARCH INSTITUTES 70
8.4.1 RESEARCH FUNDING AND COLLABORATIONS WITH COMMERCIAL ORGANIZATIONS WILL DRIVE GROWTH OF THIS SEGMENT 70
8.5 CONTRACT RESEARCH ORGANIZATIONS 73
8.5.1 ADOPTION OF CRISPR TECHNOLOGY BY CONTRACT RESEARCH ORGANIZATIONS WILL BE KEY DRIVING FACTOR 73
9 CRISPR TECHNOLOGY MARKET, BY REGION 76
9.1 INTRODUCTION 77
9.2 NORTH AMERICA 78
9.2.1 US 82
9.2.1.1 Strong scientific and industrial base will ensure sustained growth in the years to come 82
9.2.2 CANADA 84
9.2.2.1 Changes in regulations will generate opportunities in the CRISPR technology market 84
9.3 EUROPE 87
9.3.1 UK AND IRELAND 91
9.3.1.1 High activity in the area of CRISPR and CRISPR-based research 91
9.3.2 GERMANY 93
9.3.2.1 Strong base of pharma companies will favor the growth of CRISPR 93
9.3.3 FRANCE 96
9.3.3.1 Growing support and funds for CRISPR research to support the French market 96
9.3.4 REST OF EUROPE 98
9.4 ASIA PACIFIC 101
9.4.1 CHINA 105
9.4.1.1 China to register the highest growth rate in the APAC CRISPR technology market during the forecast period 105

9.4.2 JAPAN 107
9.4.2.1 Growing collaborations between universities and pharma/biotech companies to drive market growth 107
9.4.3 SOUTH KOREA 109
9.4.3.1 Strong private investments in CRISPR technology applications is the major factor driving market growth in the country 109
9.4.4 REST OF APAC 112
9.5 REST OF THE WORLD 115
10 COMPETITIVE LANDSCAPE 118
10.1 MARKET OVERVIEW 118
10.2 MARKET RANKING ANALYSIS (2017) 119
10.3 COMPETITIVE SITUATION AND TRENDS 120
10.3.1 COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS 120
10.3.2 PRODUCT LAUNCHES AND APPROVALS 121
10.3.3 ACQUISITIONS 121
10.3.4 PATENT APPROVALS 122
10.3.5 OTHER DEVELOPMENTS 123
11 COMPANY PROFILES 124
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 THERMO FISHER SCIENTIFIC 124
11.2 MERCK KGAA 127
11.3 GENSCRIPT 130
11.4 INTEGRATED DNA TECHNOLOGIES (IDT) 134
11.5 HORIZON DISCOVERY GROUP 136
11.6 AGILENT TECHNOLOGIES 140
11.7 CELLECTA, INC. 143
11.8 GENECOPOEIA, INC. 145
11.9 NEW ENGLAND BIOLABS 146
11.10 ORIGENE TECHNOLOGIES, INC. 148
11.11 SYNTHEGO CORPORATION 150
11.12 TOOLGEN, INC. 153
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX 156
12.1 DISCUSSION GUIDE 156
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 160
12.4 AVAILABLE CUSTOMIZATIONS 162
12.5 RELATED REPORTS 162
12.6 AUTHOR DETAILS 163

LIST OF TABLES

TABLE 1 CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 43
TABLE 2 CRISPR PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 44
TABLE 3 CRISPR PRODUCTS MARKET, BY REGION, 2016–2023 (USD MILLION) 44
TABLE 4 CRISPR ENZYMES MARKET, BY REGION, 2016–2023 (USD MILLION) 45
TABLE 5 CRISPR LIBRARIES MARKET, BY REGION, 2016–2023 (USD MILLION) 46
TABLE 6 CRISPR KITS MARKET, BY REGION, 2016–2023 (USD MILLION) 47
TABLE 7 SGRNA DESIGN TOOLS 48
TABLE 8 OTHER CRISPR PRODUCTS MARKET, BY REGION, 2016–2023 (USD MILLION) 48
TABLE 9 CRISPR SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 49
TABLE 10 CRISPR SERVICES MARKET, BY REGION, 2016–2023 (USD MILLION) 49
TABLE 11 CRISPR GRNA DESIGN AND VECTOR CONSTRUCTION SERVICES MARKET,
BY REGION, 2016–2023 (USD MILLION) 50
TABLE 12 CRISPR CELL LINE ENGINEERING SERVICES MARKET, BY REGION,
2016–2023 (USD MILLION) 51
TABLE 13 CRISPR SCREENING SERVICES MARKET, BY REGION, 2016–2023 (USD MILLION) 51
TABLE 14 OTHER CRISPR SERVICES MARKET, BY REGION, 2016–2023 (USD MILLION) 52
TABLE 15 CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 54
TABLE 16 CRISPR TECHNOLOGY MARKET FOR BIOMEDICAL APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 55
TABLE 17 NORTH AMERICA: CRISPR TECHNOLOGY MARKET FOR BIOMEDICAL APPLICATIONS, BY COUNTRY, 2016–2023 (USD MILLION) 55
TABLE 18 EUROPE: CRISPR TECHNOLOGY MARKET FOR BIOMEDICAL APPLICATIONS,
BY COUNTRY, 2016–2023 (USD MILLION) 56
TABLE 19 ASIA PACIFIC: CRISPR TECHNOLOGY MARKET FOR BIOMEDICAL APPLICATIONS,
BY COUNTRY, 2016–2023 (USD MILLION) 56
TABLE 20 CRISPR TECHNOLOGY MARKET FOR AGRICULTURAL APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 57
TABLE 21 NORTH AMERICA: CRISPR TECHNOLOGY MARKET FOR AGRICULTURAL APPLICATIONS, BY COUNTRY, 2016–2023 (USD MILLION) 58
TABLE 22 EUROPE: CRISPR TECHNOLOGY MARKET FOR AGRICULTURAL APPLICATIONS,
BY COUNTRY, 2016–2023 (USD MILLION) 58
TABLE 23 ASIA PACIFIC: CRISPR TECHNOLOGY MARKET FOR AGRICULTURAL APPLICATIONS, BY COUNTRY, 2016–2023 (USD MILLION) 59
TABLE 24 CRISPR TECHNOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 60
TABLE 25 NORTH AMERICA: CRISPR TECHNOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2016–2023 (USD MILLION) 60
TABLE 26 EUROPE: CRISPR TECHNOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,
BY COUNTRY, 2016–2023 (USD MILLION) 60
TABLE 27 ASIA PACIFIC: CRISPR TECHNOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,
BY REGION, 2016–2023 (USD MILLION) 61
TABLE 28 CRISPR TECHNOLOGY MARKET FOR BIOLOGICAL RESEARCH, BY REGION,
2016–2023 (USD MILLION) 62
TABLE 29 NORTH AMERICA: CRISPR TECHNOLOGY MARKET FOR BIOLOGICAL RESEARCH,
BY COUNTRY, 2016–2023 (USD MILLION) 62
TABLE 30 EUROPE: CRISPR TECHNOLOGY MARKET FOR BIOLOGICAL RESEARCH,
BY COUNTRY, 2016–2023 (USD MILLION) 62
TABLE 31 ASIA PACIFIC: CRISPR TECHNOLOGY MARKET FOR BIOLOGICAL RESEARCH,
BY COUNTRY, 2016–2023 (USD MILLION) 63
TABLE 32 CRISPR TECHNOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION) 65
TABLE 33 CRISPR: CLINICAL PIPELINE 66
TABLE 34 CRISPR TECHNOLOGY MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2016–2023 (USD MILLION) 66
TABLE 35 NORTH AMERICA: CRISPR TECHNOLOGY MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION) 67
TABLE 36 EUROPE: CRISPR TECHNOLOGY MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION) 67
TABLE 37 ASIA PACIFIC: CRISPR TECHNOLOGY MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION) 67
TABLE 38 LIST OF SOME OF THE AGRICULTURAL AND INDUSTRIAL CRISPR-BASED PRODUCTS/APPLICATIONS 68
TABLE 39 CRISPR TECHNOLOGY MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2023 (USD MILLION) 68
TABLE 40 NORTH AMERICA: CRISPR TECHNOLOGY MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION) 69
TABLE 41 EUROPE: CRISPR TECHNOLOGY MARKET FOR BIOTECHNOLOGY COMPANIES,
BY COUNTRY, 2016–2023 (USD MILLION) 69
TABLE 42 ASIA PACIFIC: CRISPR TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2016–2023 (USD MILLION) 70
TABLE 43 LIST OF SOME OF THE MAJOR RESEARCH COLLABORATIONS IN THE CRISPR TECHNOLOGY MARKET, 2015–2018 70
TABLE 44 CRISPR TECHNOLOGY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES,
BY REGION, 2016–2023 (USD MILLION) 71
TABLE 45 NORTH AMERICA: CRISPR TECHNOLOGY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2016–2023 (USD MILLION) 72
TABLE 46 EUROPE: CRISPR TECHNOLOGY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2016–2023 (USD MILLION) 72
TABLE 47 ASIA PACIFIC: CRISPR TECHNOLOGY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2016–2023 (USD MILLION) 72
TABLE 48 CRISPR TECHNOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS,
BY REGION, 2016–2023 (USD MILLION) 73
TABLE 49 NORTH AMERICA: CRISPR TECHNOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2023 (USD MILLION) 74
TABLE 50 EUROPE: CRISPR TECHNOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2023 (USD MILLION) 74
TABLE 51 ASIA PACIFIC: CRISPR TECHNOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2023 (USD MILLION) 75
TABLE 52 CRISPR TECHNOLOGY MARKET, BY REGION, 2016–2023 (USD MILLION) 77
TABLE 53 NORTH AMERICA: CRISPR TECHNOLOGY MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 80
TABLE 54 NORTH AMERICA: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 80
TABLE 55 NORTH AMERICA: CRISPR PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 80
TABLE 56 NORTH AMERICA: CRISPR SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 81
TABLE 57 NORTH AMERICA: CRISPR TECHNOLOGY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 81
TABLE 58 NORTH AMERICA: CRISPR TECHNOLOGY MARKET, BY END USER,
2016–2023 (USD MILLION) 81
TABLE 59 US: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 82
TABLE 60 US: CRISPR PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 83
TABLE 61 US: CRISPR SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 83
TABLE 62 US: CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 83
TABLE 63 US: CRISPR TECHNOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION) 84
TABLE 64 CANADA: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 85
TABLE 65 CANADA: CRISPR PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 85
TABLE 66 CANADA: CRISPR SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 85
TABLE 67 CANADA: CRISPR TECHNOLOGY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 86
TABLE 68 CANADA: CRISPR TECHNOLOGY MARKET, BY END USER,
2016–2023 (USD MILLION) 86
TABLE 69 EUROPE: CRISPR TECHNOLOGY MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 89
TABLE 70 EUROPE: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 89
TABLE 71 EUROPE: CRISPR PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 89
TABLE 72 EUROPE: CRISPR SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 90
TABLE 73 EUROPE: CRISPR TECHNOLOGY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 90
TABLE 74 EUROPE: CRISPR TECHNOLOGY MARKET, BY END USER,
2016–2023 (USD MILLION) 90
TABLE 75 UK AND IRELAND: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 92
TABLE 76 UK AND IRELAND: CRISPR PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 92
TABLE 77 UK AND IRELAND: CRISPR SERVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 92
TABLE 78 UK AND IRELAND: CRISPR TECHNOLOGY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 93
TABLE 79 UK AND IRELAND: CRISPR TECHNOLOGY MARKET, BY END USER,
2016–2023 (USD MILLION) 93
TABLE 80 GERMANY: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 94
TABLE 81 GERMANY: CRISPR PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 94
TABLE 82 GERMANY: CRISPR SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 95
TABLE 83 GERMANY: CRISPR TECHNOLOGY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 95
TABLE 84 GERMANY: CRISPR TECHNOLOGY MARKET, BY END USER,
2016–2023 (USD MILLION) 95
TABLE 85 FRANCE: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 96
TABLE 86 FRANCE: CRISPR PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 97
TABLE 87 FRANCE: CRISPR SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 97
TABLE 88 FRANCE: CRISPR TECHNOLOGY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 97
TABLE 89 FRANCE: CRISPR TECHNOLOGY MARKET, BY END USER,
2016–2023 (USD MILLION) 98
TABLE 90 LIST OF MEETINGS, CONFERENCE, AND WORKSHOPS ON CRISPR IN ROE
2016-2018 99
TABLE 91 ROE: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 99
TABLE 92 ROE: CRISPR PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 100
TABLE 93 ROE: CRISPR SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 100
TABLE 94 ROE: CRISPR TECHNOLOGY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 100
TABLE 95 ROE: CRISPR TECHNOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION) 101
TABLE 96 APAC: CRISPR TECHNOLOGY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 103
TABLE 97 APAC: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 103
TABLE 98 APAC: CRISPR PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 103
TABLE 99 APAC: CRISPR SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 104
TABLE 100 APAC: CRISPR TECHNOLOGY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 104
TABLE 101 APAC: CRISPR TECHNOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION) 104
TABLE 102 CHINA: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 105
TABLE 103 CHINA: CRISPR PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 106
TABLE 104 CHINA: CRISPR SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 106
TABLE 105 CHINA: CRISPR TECHNOLOGY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 106
TABLE 106 CHINA: CRISPR TECHNOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION) 107
TABLE 107 JAPAN: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 108
TABLE 108 JAPAN: CRISPR PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 108
TABLE 109 JAPAN: CRISPR SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 108
TABLE 110 JAPAN: CRISPR TECHNOLOGY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 109
TABLE 111 JAPAN: CRISPR TECHNOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION) 109
TABLE 112 SOUTH KOREA: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 110
TABLE 113 SOUTH KOREA: CRISPR PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 110
TABLE 114 SOUTH KOREA: CRISPR SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 111
TABLE 115 SOUTH KOREA: CRISPR TECHNOLOGY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 111
TABLE 116 SOUTH KOREA: CRISPR TECHNOLOGY MARKET, BY END USER,
2016–2023 (USD MILLION) 111
TABLE 117 ROAPAC: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 113
TABLE 118 ROAPAC: CRISPR PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 113
TABLE 119 ROAPAC: CRISPR SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 113
TABLE 120 ROAPAC: CRISPR TECHNOLOGY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 114
TABLE 121 ROAPAC: CRISPR TECHNOLOGY MARKET, BY END USER,
2016–2023 (USD MILLION) 114
TABLE 122 ROW: CRISPR TECHNOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 115
TABLE 123 ROW: CRISPR PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 116
TABLE 124 ROW: CRISPR SERVICES MARKET, BY TYPE, 2016–2023 (USD MILLION) 116
TABLE 125 ROW: CRISPR TECHNOLOGY MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 116
TABLE 126 ROW: CRISPR TECHNOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION) 117
TABLE 127 CRISPR TECHNOLOGY MARKET RANKING, BY KEY PLAYER (2017) 119
TABLE 128 COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS (2015–2018) 120
TABLE 129 PRODUCT LAUNCHES (2015–2018) 121
TABLE 130 ACQUISITIONS, 2015–2018 121
TABLE 131 PATENT APPROVALS (2015–2018) 122
TABLE 132 OTHER DEVELOPMENTS (2015–2018) 123


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 21
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY SIZE, DESIGNATION,
AND REGION 24
FIGURE 3 MARKET DATA TRIANGULATION METHODOLOGY 27
FIGURE 4 CRISPR TECHNOLOGY MARKET, BY PRODUCT AND SERVICE,
2018 VS. 2023 (USD MILLION) 29
FIGURE 5 CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION) 30
FIGURE 6 CRISPR TECHNOLOGY MARKET, BY END USER, 2018 VS. 2023 (USD MILLION) 30
FIGURE 7 GEOGRAPHICAL SNAPSHOT OF THE CRISPR TECHNOLOGY MARKET 31
FIGURE 8 GROWTH OF THIS MARKET IS EXPECTED TO BE DRIVEN BY THE RISING AVAILABILITY OF FUNDING AND GROWING APPLICATIONS OF CRISPR 32
FIGURE 9 PHARMA AND BIOPHARMA COMPANIES ARE EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF EUROPEAN MARKET IN 2018 33
FIGURE 10 BIOMEDICAL APPLICATIONS ARE EXPECTED TO ACCOUNT SHARE OF
THE MARKET IN 2018 34
FIGURE 11 CRISPR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 35
FIGURE 12 TIMELINE FOR MAJOR EVENTS IN CRISPR PATENT WAR 40
FIGURE 13 CRISPR PRODUCTS TO ACCOUNT FOR THE LARGER SHARE OF THE CRISPR TECHNOLOGY MARKET IN 2018 43
FIGURE 14 CRISPR TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 77
FIGURE 15 NORTH AMERICAN CRISPR TECHNOLOGY MARKET SNAPSHOT 79
FIGURE 16 EUROPE: CRISPR TECHNOLOGY MARKET SNAPSHOT 88
FIGURE 17 APAC: CRISPR TECHNOLOGY MARKET SNAPSHOT 102
FIGURE 18 KEY DEVELOPMENTS IN THE CRISPR TECHNOLOGY MARKET (2015–2018) 118
FIGURE 19 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017) 124
FIGURE 20 MERCK KGAA: COMPANY SNAPSHOT (2017) 127
FIGURE 21 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2017) 130
FIGURE 22 HORIZON DISCOVERY GROUP PLC: COMPANY SNAPSHOT (2017) 136
FIGURE 23 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2017) 140
FIGURE 24 TOOLGEN: COMPANY SNAPSHOT (2017) 153


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[CRISPR技術の世界市場予測(~2023年)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆